Detergent-Free Decellularization of the Human Pancreas for Soluble Extracellular Matrix (ECM) Production.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
04 09 2020
Historique:
entrez: 21 9 2020
pubmed: 22 9 2020
medline: 1 12 2020
Statut: epublish

Résumé

Islet transplantation (ITx) has the potential to become the standard of care in beta cell replacement medicine but its results remain inferior to those obtained with whole pancreas transplantation. The protocols currently used for human islet isolation are under scrutiny because they are based on the enzymatic digestion of the organ, whereby the pancreas is demolished, its connections to the body are lost and islets are irreversibly damaged. Islet damage is characterized by critical factors such as the destruction of the extracellular matrix (ECM), which represents the 3D framework of the islet niche and whose loss is incompatible with islet euphysiology. Researchers are proposing the use of ECM-based scaffolds derived from the mammalian pancreas to address this problem and ultimately improve islet viability, function, and lifespan. Currently available methods to obtain such scaffolds are harsh because they are largely detergent based. Thus, we propose a new, detergent-free method that creates less ECM damage and can preserve critical components of pancreatic ECM. The results show that the newly developed decellularization protocol allowed the achievement of complete DNA clearance while the ECM components were retained. The ECM obtained was tested for cytotoxicity and encapsulated with human pancreatic islets which showed a positive cellular behavior with insulin secretion when stimulated with glucose challenge. Collectively, we propose a new method for the decellularization of the human pancreas without the use of conventional ionic and non-ionic chemical detergents. This protocol and the ECM obtained with it could be of use for both in vitro and in vivo applications.

Identifiants

pubmed: 32955501
doi: 10.3791/61663
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Auteurs

Riccardo Tamburrini (R)

Department of Surgery, Wake Forest Baptist Medical Center; Department of General Surgery, PhD Program in Experimental Medicine, University of Pavia; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Deborah Chaimov (D)

Department of Surgery, Wake Forest Baptist Medical Center; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Amish Asthana (A)

Department of Surgery, Wake Forest Baptist Medical Center; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Carlo Gazia (C)

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine; Department of Surgery, Tor Vergata University of Rome.

Kevin Enck (K)

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Sean M Muir (SM)

Wake Forest University College of Arts and Science.

Justine Mariam Aziz (JM)

Wake Forest University School of Medicine.

Sandrine Lablanche (S)

Laboratory of Fundamental and Applied Bioenergetics (LBFA), and Environmental and System Biology (BEeSy), Grenoble Alps University.

Emily Tubbs (E)

Laboratory of Fundamental and Applied Bioenergetics (LBFA), and Environmental and System Biology (BEeSy), Grenoble Alps University.

Alice A Tomei (AA)

Department of Biomedical Engineering, University of Miami; Diabetes Research Institute, University of Miami Miller School of Medicine.

Mark Van Dyke (M)

Department of Biomedical Engineering and Mechanics, School of Biomedical Engineering and Sciences, Virginia Polytechnic Institute and State University.

Shay Soker (S)

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Emmanuel C Opara (EC)

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine.

Giuseppe Orlando (G)

Department of Surgery, Wake Forest Baptist Medical Center; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine; gorlando@wakehealth.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH